These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24876779)

  • 1. Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.
    Ye W; Montgomery W; Kadziola Z; Liu L; Xue H; Stensland MD; Treuer T
    Neuropsychiatr Dis Treat; 2014; 10():869-78. PubMed ID: 24876779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
    Montgomery W; Treuer T; Ye W; Xue HB; Wu SH; Liu L; Kadziola Z; Stensland MD; Ascher-Svanum H
    Neuropsychiatr Dis Treat; 2014; 10():1287-96. PubMed ID: 25031537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia.
    Ascher-Svanum H; Zhao F; Detke HC; Nyhuis AW; Lawson AH; Stauffer VL; Montgomery W; Witte MM; McDonnell DP
    BMC Psychiatry; 2011 Sep; 11():152. PubMed ID: 21943257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study.
    Ye W; Fujikoshi S; Nakahara N; Takahashi M; Ascher-Svanum H; Ohmori T
    Pragmat Obs Res; 2012; 3():41-49. PubMed ID: 27774016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer-term treatment of patients with bipolar disorder: a 9-month observational study in Central and Eastern Europe, the Middle East and Africa.
    Okasha TA; Kucukalić A; Nasr AA; Zelman M; Karamustafalioğlu O; Sir A; Harrison G; Treuer T
    Curr Med Res Opin; 2009 Aug; 25(8):1889-900. PubMed ID: 19538106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the Worldwide Schizophrenia Outpatients Health Outcomes (W-SOHO) study.
    Hong J; Novick D; Brugnoli R; Karagianis J; Dossenbach M; Haro JM
    BMC Psychiatry; 2012 Dec; 12():218. PubMed ID: 23206324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia.
    Ascher-Svanum H; Nyhuis AW; Faries DE; Kinon BJ; Baker RW; Shekhar A
    Schizophr Bull; 2008 Nov; 34(6):1163-71. PubMed ID: 18156640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review.
    Xue HB; Liu L; Zhang H; Montgomery W; Treuer T
    Neuropsychiatr Dis Treat; 2014; 10():841-64. PubMed ID: 24876777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy.
    Montgomery W; Liu L; Stensland MD; Xue HB; Treuer T; Ascher-Svanum H
    Clinicoecon Outcomes Res; 2013; 5():407-18. PubMed ID: 23983478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.
    Haro JM; Salvador-Carulla L
    CNS Drugs; 2006; 20(4):293-301. PubMed ID: 16599647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.
    Xiao L; Ganocy SJ; Findling RL; Chang K; DelBello MP; Kane JM; Tohen M; Xiang YT; Correll CU
    J Clin Psychiatry; 2017; 78(9):e1158-e1166. PubMed ID: 28922591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.
    Kemp DE; Correll CU; Tohen M; Delbello MP; Ganocy SJ; Findling RL; Chang K
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):522-30. PubMed ID: 24111982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
    Rosa F; Schreiner A; Thomas P; Sherif T
    Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2003; (1):CD001359. PubMed ID: 12535408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study.
    Novick D; Haro JM; Suarez D; Marques-Teixeira J; Naber D
    Int Clin Psychopharmacol; 2008 Jul; 23(4):203-8. PubMed ID: 18545058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.